MDB Capital Holdings, LLC (NASDAQ:MDBH) Short Interest Up 93.4% in July

MDB Capital Holdings, LLC (NASDAQ:MDBH) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 3,170 shares, an increase of 93.4% from the June 30th total of 1,639 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average trading volume of 1,140 shares, the short-interest ratio is presently 2.8 days.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Citadel Advisors LLC bought a new stake in shares of MDB Capital in the third quarter worth about $43,000. DRW Securities LLC bought a new position in MDB Capital during the fourth quarter valued at approximately $40,000. Finally, Raymond James Financial Inc. purchased a new position in MDB Capital during the 2nd quarter valued at approximately $27,000. Hedge funds and other institutional investors own 0.35% of the company’s stock.

MDB Capital Stock Performance

MDBH stock opened at $3.05 on Thursday. MDB Capital has a one year low of $2.45 and a one year high of $4.80. The company’s fifty day moving average price is $3.24 and its 200-day moving average price is $3.29. The company has a market capitalization of $31.41 million, a PE ratio of -1.44 and a beta of 1.17.

MDB Capital (NASDAQ:MDBH) last issued its earnings results on Thursday, May 14th. The company reported ($0.65) earnings per share for the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of MDB Capital in a research report on Thursday, July 2nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

About MDB Capital

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.